Publication | Open Access
Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes
179
Citations
34
References
2018
Year
In-home use of MiniMed 670G system Auto Mode for 3 months by children with T1D, similar to MiniMed 670G system use by adolescents and adults with T1D, was safe and associated with reduced HbA<sub>1c</sub> levels and increased time in target glucose range, compared with baseline.
| Year | Citations | |
|---|---|---|
Page 1
Page 1